Your browser doesn't support javascript.
loading
Results of the c-TRAK TN trial: a clinical trial utilising ctDNA mutation tracking to detect molecular residual disease and trigger intervention in patients with moderate- and high-risk early-stage triple-negative breast cancer.
Turner, N C; Swift, C; Jenkins, B; Kilburn, L; Coakley, M; Beaney, M; Fox, L; Goddard, K; Garcia-Murillas, I; Proszek, P; Hall, P; Harper-Wynne, C; Hickish, T; Kernaghan, S; Macpherson, I R; Okines, A F C; Palmieri, C; Perry, S; Randle, K; Snowdon, C; Stobart, H; Wardley, A M; Wheatley, D; Waters, S; Winter, M C; Hubank, M; Allen, S D; Bliss, J M.
Afiliación
  • Turner NC; Breast Cancer Now Research Centre, The Institute of Cancer Research, London, UK; Breast Unit, The Royal Marsden Hospital, London, UK. Electronic address: Nick.Turner@icr.ac.uk.
  • Swift C; The Institute of Cancer Research, London, UK; The Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK.
  • Jenkins B; Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, UK.
  • Kilburn L; Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, UK.
  • Coakley M; The Institute of Cancer Research, London, UK; The Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK.
  • Beaney M; The Institute of Cancer Research, London, UK.
  • Fox L; Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, UK.
  • Goddard K; Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, UK.
  • Garcia-Murillas I; The Institute of Cancer Research, London, UK.
  • Proszek P; NIHR Centre for Molecular Pathology, Royal Marsden Hospital, London, UK.
  • Hall P; University of Edinburgh, Edinburgh, UK.
  • Harper-Wynne C; Maidstone Hospital, Maidstone and Tunbridge Wells NHS Trust, Maidstone, UK.
  • Hickish T; University Hospitals Dorset NHS Foundation Trust, Bournemouth, UK.
  • Kernaghan S; Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, UK.
  • Macpherson IR; The Beatson West of Scotland Cancer Centre, Glasgow, UK.
  • Okines AFC; Breast Unit, The Royal Marsden Hospital, London, UK.
  • Palmieri C; Clatterbridge Cancer Centre NHS Trust, Liverpool, Wirral, UK.
  • Perry S; Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, UK.
  • Randle K; Independent Cancer Patients' Voice, London, UK.
  • Snowdon C; Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, UK.
  • Stobart H; Independent Cancer Patients' Voice, London, UK.
  • Wardley AM; Outreach Research & Innovation Group Ltd, Manchester, UK.
  • Wheatley D; Royal Cornwall Hospitals NHS Trust, Truro, UK.
  • Waters S; Velindre Cancer Centre, Velindre University NHS Trust, Cardiff, UK.
  • Winter MC; Sheffield Teaching Hospitals NHS Foundation Trust, Weston Park Hospital, Sheffield, UK.
  • Hubank M; The Institute of Cancer Research, London, UK; The Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK.
  • Allen SD; The Royal Marsden NHS Foundation Trust, Sutton, Surrey, UK.
  • Bliss JM; Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, UK.
Ann Oncol ; 34(2): 200-211, 2023 02.
Article en En | MEDLINE | ID: mdl-36423745
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasia Residual / Neoplasias de la Mama Triple Negativas / ADN Tumoral Circulante / Antineoplásicos Inmunológicos Tipo de estudio: Clinical_trials / Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasia Residual / Neoplasias de la Mama Triple Negativas / ADN Tumoral Circulante / Antineoplásicos Inmunológicos Tipo de estudio: Clinical_trials / Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article